A cannabis based drug developed by GW Pharmaceuticals; Sativex is a treatment for pain in Multiple Sclerosis.
Originally approved in Canada, Sativex is now licensed in the UK
Sativex Cannabis based prescription medicine
Month: August 2015
A cannabis based drug developed by GW Pharmaceuticals; Sativex is a treatment for pain in Multiple Sclerosis.
Originally approved in Canada, Sativex is now licensed in the UK
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.